Showing results (181-190 of 210) with videos related to
Sort By:
Pageof 21
Pediatric Blood & Cancer|November 19, 2019
Low-grade fibromyxoid sarcoma: A report of the Cooperative Weichteilsarkom Studiengruppe (CWS)Monika Scheer, Christian Vokuhl, Iris Veit-Friedrich, et al.Cancer|August 2, 2023
Outcome of rare primary malignant bone sarcoma treated with multimodal therapy: Results from the EUROpean Bone Over 40 Sarcoma Study (EURO-B.O.S.S.)Emanuela Palmerini, Peter Reichardt, Kirsten Sundby Hall, et al.Pediatric Blood & Cancer|February 19, 2013
Survival following disease recurrence of primary localized alveolar rhabdomyosarcomaTobias M Dantonello, Christoph Int-Veen, Andreas Schuck, et al.Anticancer Research|October 28, 2025
Osteosarcoma of the Diaphysis: A Report from the Cooperative Osteosarcoma Study Group (COSS)Stefan S Bielack, Claudia Blattmann, Leo Kager, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2005
Osteosarcoma relapse after combined modality therapy: an analysis of unselected patients in the Cooperative Osteosarcoma Study Group (COSS)Beate Kempf-Bielack, Stefan S Bielack, Heribert Jürgens, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 15, 2003
Osteosarcoma of the pelvis: experience of the Cooperative Osteosarcoma Study GroupToshifumi Ozaki, Silke Flege, Matthias Kevric, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 19, 2019
Rapid, complete and sustained tumour response to the TRK inhibitor larotrectinib in an infant with recurrent, chemotherapy-refractory infantile fibrosarcoma carrying the characteristic ETV6-NTRK3 gene fusionS S Bielack, M C Cox, M Nathrath, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 2020
Rapid, complete and sustained tumour response to the TRK inhibitor larotrectinib in an infant with recurrent, chemotherapy-refractory infantile fibrosarcoma carrying the characteristic ETV6-NTRK3 gene fusionS S Bielack, M C Cox, M Nathrath, et al.Pediatric Blood & Cancer|July 1, 2016
A phase II study of clinical activity of SCH 717454 (robatumumab) in patients with relapsed osteosarcoma and Ewing sarcomaPeter M Anderson, Stefan S Bielack, Richard G Gorlick, et al.European Journal of Cancer (Oxford, England : 1990)|October 3, 2022
Osteosarcoma and causes of death: A report of 1520 deceased patients from the Cooperative Osteosarcoma Study Group (COSS)Stefan S Bielack, Claudia Blattmann, Arndt Borkhardt, et al.Pageof 21